Cargando…

Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010–2011 to 2015–2016, Canada

Age-related differences in influenza B lineage detection were explored in the community-based Canadian Sentinel Practitioner Surveillance Network (SPSN) from 2010–2011 to 2015–2016. Whereas >80% of B(Victoria) cases were <40 years old, B(Yamagata) cases showed a bimodal age distribution with 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skowronski, Danuta M, Chambers, Catharine, De Serres, Gaston, Sabaiduc, Suzana, Winter, Anne-Luise, Dickinson, James A, Gubbay, Jonathan B, Fonseca, Kevin, Drews, Steven J, Charest, Hugues, Martineau, Christine, Krajden, Mel, Petric, Martin, Bastien, Nathalie, Li, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853978/ https://www.ncbi.nlm.nih.gov/pubmed/28934439 http://dx.doi.org/10.1093/infdis/jix393

Ejemplares similares

Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015–2016 Season in Canada
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010–2011 to 2016–2017
por: Skowronski, Danuta M, et al.
Publicado: (2020)

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016–2017 and 2017–2018 Epidemics in Canada
por: Skowronski, Danuta M, et al.
Publicado: (2020)

A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season
por: Skowronski, Danuta M., et al.
Publicado: (2016)

Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?
por: Chambers, Catharine, et al.
Publicado: (2018)

Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ‎possible cohort effect following the 2009 influenza pandemic
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018
por: Skowronski, Danuta M, et al.
Publicado: (2018)

Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses
por: Skowronski, Danuta M., et al.
Publicado: (2014)

Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020
por: Skowronski, Danuta M, et al.
Publicado: (2020)

Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009
por: Skowronski, Danuta M, et al.
Publicado: (2011)

Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23
por: Skowronski, Danuta M, et al.
Publicado: (2023)

Other Respiratory Viruses Are Important Contributors to Adult Respiratory Hospitalizations and Mortality Even During Peak Weeks of the Influenza Season
por: Gilca, Rodica, et al.
Publicado: (2014)

Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada
por: Kim, Shinhye, et al.
Publicado: (2022)

Influenza Classification Suite: An automated Galaxy workflow for rapid influenza sequence analysis
por: Eisler, Diane, et al.
Publicado: (2020)

SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada
por: El Adam, Shiraz, et al.
Publicado: (2022)

Case series of rash associated with influenza B in school children
por: Skowronski, Danuta M, et al.
Publicado: (2015)

Avian Influenza A(H7N9) Virus Infection in 2 Travelers Returning from China to Canada, January 2015
por: Skowronski, Danuta M., et al.
Publicado: (2016)

BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12–17 Years, by Dosing Interval and Duration
por: Ionescu, Iulia G, et al.
Publicado: (2023)

Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015
por: Gilca, Rodica, et al.
Publicado: (2015)

Physical, Psychological, and Cognitive Profile of Post-COVID Conditions in Healthcare Workers, Quebec, Canada
por: Carazo, Sara, et al.
Publicado: (2022)

Community‐acquired respiratory viruses and co‐infection among patients of Ontario sentinel practices, April 2009 to February 2010
por: Peci, Adriana, et al.
Publicado: (2012)

Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
por: Skowronski, Danuta M., et al.
Publicado: (2022)

Increase in Hospital Admissions for Severe Influenza A/B among Travelers on Cruise Ships to Alaska, 2015
por: Payne, Michael, et al.
Publicado: (2018)

Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings
por: Boikos, Constantina, et al.
Publicado: (2016)

Ecological Fallacy, Nonspecific Outcomes, and the Attribution of Disproportionate Vaccine Benefits
por: De Serres, Gaston, et al.
Publicado: (2018)

Role of Egg-adaptation Mutations in Low Influenza A(H3N2) Vaccine Effectiveness During the 2012–2013 Season
por: Skowronski, Danuta M, et al.
Publicado: (2018)

Evidence in a Cluster Randomized Controlled Trial of Increased 2009 Pandemic Risk Associated With 2008–2009 Seasonal Influenza Vaccine Receipt
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2022)

Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2022)

Randomized Controlled Ferret Study to Assess the Direct Impact of 2008–09 Trivalent Inactivated Influenza Vaccine on A(H1N1)pdm09 Disease Risk
por: Skowronski, Danuta M., et al.
Publicado: (2014)

Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement
por: De Serres, Gaston, et al.
Publicado: (2017)

Prevalence of risk factors for acquiring measles during the 2011 outbreak in Quebec and impact of the province-wide school-based vaccination campaign on population immunity
por: Billard, Marie-Noëlle, et al.
Publicado: (2017)

Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2021)

Caution Required in the Use of Administrative Data and General Laboratory Submissions for Influenza Vaccine Effectiveness Estimation
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Measles in Canada Between 2002 and 2013
por: De Serres, Gaston, et al.
Publicado: (2015)

Burden of Severe Illness Associated With Laboratory-Confirmed Influenza in Adults Aged 50–64 Years, 2010–2011 to 2016–2017
por: Kim, Philip, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d39t69c485otep4bdaov9p7cfh